Key Takeaways TSM shares jumped 18.2% in a month, topping peers and trading near a 52-week high.AI chip sales tripled in 2024 and are expected to double again in 2025, fueling TSM's growth.Soft PC and smartphone demand and higher fab costs pose short-term challenges for TSM.Taiwan Semiconductor Manufacturing Company (TSM) , also known as TSMC, shares have rallied 18.2% over the past month, outperforming the Zacks Computer and Technology sector’s gain of 6.3%.TSM stock has also outperformed major semiconduct ...

Key Takeaways Bruker received $10M in new NMR instrumentation orders from NYSBC, Delaware, and Northwestern. BRKR's systems, backed by NIH and NSF funding, will be delivered and installed in 2026. The new orders strengthen Bruker's BioSpin segment and lifted shares 6.2% to $36.98. Bruker Corporation (BRKR) recently received new orders for advanced Nuclear Magnetic Resonance (“NMR”) instrumentation from the New York Structural Biology Center (“NYSBC”), the University of Delaware and Northwestern University. ...

Key Takeaways CLPT introduced a robotic system integrating its neuro-navigation software with KUKA's arm.CLPT's platform targets biopharma partners launching complex brain-delivered cell and gene therapies.Collaborations and software focus reduce risk, speed timelines, and position CLPT for long-term growth.ClearPoint Neuro (CLPT) recently unveiled the development of its proprietary Robotic Neuro-Navigation System, a move that positions the company to contribute to robotics, neurosurgery, and advanced drug ...

Key Takeaways Hologic celebrates 19 years of ringing Nasdaq's bell to spotlight early breast cancer detection.Hologic's Breast Health arm turns a corner as new sales structure drives stronger execution.New AI-powered mammography and Envision platform highlight Hologic's tech-driven clinical progress.Hologic (HOLX) is a long-standing innovator in developing and advancing technologies to help detect and treat breast cancer. The Massachusetts-based MedTech firm rang the Nasdaq opening bell for the 19th consecu ...

Key Takeaways Canadian Natural's oil sands output rose 13% in Q2 2025, reaching 464,000 barrels per day.Stable, low-decline assets and cost efficiencies underpin CNQ's resilient production base.Strong free cash flow and balance sheet support reinvestment in growth and upgrading projects.Canadian Natural Resources Limited ((CNQ) continues to demonstrate the strength of its Oil Sands Mining & Upgrading operations, underscoring the reliability that anchors its broader production profile. In the last reported q ...

Pharmaceutical shares just witnessed their strongest week in 23 years, thanks to Pfizer's (PFE) major drug-pricing and tariff deal with the U.S. government that helped ease long-standing pressures on the industry, per a Bloomberg article, as quoted on Yahoo Finance.The S&P 500 Pharmaceuticals Index jumped 10.8% last week, marking its strongest performance since July 2002. With these gains, the index is now up only 6.6% for the year, still underperforming the S&P 500, which is up 14.4% (as of Oct. 3, 2025).P ...

CEA Industries Inc. (BNC) shares soared 7% in the last trading session to close at $8.13. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 55.5% loss over the past four weeks.Shares of CEA Industries are likely to have gained on optimism surrounding its strategic initiatives. The company is advancing its Digital Asset Treasury (DAT) strategy, aiming to own 1% of BNB’s total supply by the end of 2025 to enhance long-term value. Als ...

Tarsus Pharmaceuticals, Inc. (TARS) shares ended the last trading session 10.9% higher at $65.17. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 2.3% gain over the past four weeks.The sudden rise in the stock price can be attributed to the growing investor optimism regarding the continued strong uptake of Tarsus Pharmaceuticals’ only marketed product, Xdemvy (lotilaner ophthalmic solution) 0.25%, approved for trea ...

Bally's (BALY) shares soared 6.4% in the last trading session to close at $13.26. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 24.6% gain over the past four weeks.Bally’s recent stock rally likely reflects investor enthusiasm surrounding the company’s strategic transformation and improving business outlook. The planned sale of Bally’s International Interactive to Intralot for €2.7 billion has been perceived as a value-creating ...

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Pagaya Technologies Ltd. (PGY) : This product-focused technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 12.3% over the last 60 days.Sumitomo Mitsui Financial Group, Inc. (SMFG) : This company that provides commercial banking, leasing, securities, consumer finance, and other services has seen the Zacks Consensus Estimate for its current year earnings increasing 7.2% over the last 60 days.HF ...